GELITA, a global leader in collagen proteins and excipient innovations, will showcase its latest breakthroughs at CPHI Worldwide 2025, taking place October 28 – 30 in Frankfurt, Germany. At booth 3.0D37, you can experience first-hand how GELITA is driving the future of softgel technologies and bioscience applications.

As the recognized expert for softgel gelatin and collagen-based excipients, GELITA offers specialized solutions designed to meet today’s most demanding industry needs:

The Softgel Specialty Portfolio includes solutions for revolutionary rapid fill release, enabling true enteric soft capsules, leaking prevention or avoiding cross-linking. These solutions offer pharma companies greater flexibility in formulation and improved stability for sensitive ingredients.

Endotoxin Controlled Excipients for Bioscience Applications are specifically developed for advanced uses in vaccine stabilization, 3D bioprinting, regenerative medicine, and medical devices. With stringent endotoxin control, these excipients support maximum safety and efficacy, opening up new pathways in drug delivery and biomedical engineering.

Visitors to GELITA’s booth will not only discover these innovations but also benefit from direct engagement with experts from the GELITA Pharma Institute, who will be available for one-on-one consultations to help tailor solutions to individual project challenges.

As part of the program, GELITA is also hosting a scientific lecture:

Title: The Role of Non-Animal Recombinant Collagen Proteins in Biomedical Applications: From Vaccine Stabilization to Artificial Organs

Date & Time: Tuesday, October 28, 2025, at 1:30 PM

With its pioneering developments in softgel and bioscience excipients, GELITA is setting new standards in product performance, safety, and innovation. Don’t miss the opportunity to meet the leaders in excipient innovation at CPHI Frankfurt 2025 – Booth 3.0D37.